These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 218991)

  • 1. The effects of L-dopa on in vitro and in vivo calcitonin release from medullary thyroid carcinoma.
    Baylin SB; Hsu TH; Stevens SA; Kallman CH; Trump DL; Beaven MA
    J Clin Endocrinol Metab; 1979 Mar; 48(3):408-14. PubMed ID: 218991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of L-dopa and bromocriptine on calcitonin secretion in medullary thyroid carcinoma.
    Spiler IJ; Kapcala LP; Graze K; Gagel RF; Feldman ZT; Biller B; Tashjian AH; Reichlin S
    J Clin Endocrinol Metab; 1980 Oct; 51(4):806-9. PubMed ID: 7419666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serum calcitonin levels after a 1-minute calcium injection and after pentagastrin injection in the diagnosis of medullary thyroid carcinoma.
    Rude RK; Singer FR
    J Clin Endocrinol Metab; 1977 May; 44(5):980-3. PubMed ID: 858780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentagastrin and glucagon stimulate serum somatostatin-like immunoreactivity in man.
    Epstein S; Berelowitz M; Bell NH
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1227-31. PubMed ID: 6108330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
    Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
    Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and L-dopa: inhibition of thyrotropin-stimulated thyroidal thyroxine release.
    Maayan ML; Sellitto RV; Volpert EM
    Endocrinology; 1986 Feb; 118(2):632-6. PubMed ID: 2867890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer.
    Machens A; Hoffmann F; Sekulla C; Dralle H
    Endocr Relat Cancer; 2009 Dec; 16(4):1291-8. PubMed ID: 19726541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin in human medullary thyroid carcinomas.
    Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation tests for diagnosis of medullary thyroid carcinoma.
    Sizemore GW; Go VL
    Mayo Clin Proc; 1975 Feb; 50(2):53-6. PubMed ID: 1117754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
    Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
    Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of pentagastrin and calcium as thyrocalcitonin secretagogues in the early diagnosis of medullary carcinoma of the thyroid gland.
    Linehan WM; Farrell RE; Cooper CW; Wells SA
    Surg Forum; 1977; 28():110-2. PubMed ID: 617389
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose calcium versus pentagastrin for stimulation of calcitonin in chronic hemodialysis patients: a pilot study.
    Thiem U; Marculescu R; Cejka D; Gessl A; Borchhardt K
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4704-11. PubMed ID: 25215555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery.
    Schott M; Willenberg HS; Sagert C; Nguyen TB; Schinner S; Cohnen M; Cupisti K; Eisenberger CF; Knoefel WT; Scherbaum WA
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):405-9. PubMed ID: 17302876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination?
    Machens A; Hauptmann S; Dralle H
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2234-8. PubMed ID: 18364379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum calcitonin after pentagastrin stimulation in patients with bronchogenic and breast cancer compared to that in patients with medullary thyroid carcinoma.
    Samaan NA; Castillo S; Schultz PN; Khalil KG; Johnston DA
    J Clin Endocrinol Metab; 1980 Aug; 51(2):237-41. PubMed ID: 6249833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer.
    Colombo C; Verga U; Mian C; Ferrero S; Perrino M; Vicentini L; Dazzi D; Opocher G; Pelizzo MR; Beck-Peccoz P; Fugazzola L
    J Clin Endocrinol Metab; 2012 Mar; 97(3):905-13. PubMed ID: 22170709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
    Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
    J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine and calcitonin release from medullary thyroid carcinoma.
    Farndon JR; Lewis KR; Dale JK; Hinshaw WM; Dilley WG; Wells SA
    Cancer; 1983 Apr; 51(7):1221-5. PubMed ID: 6130834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.